Groundbreaking Global Study Establishes First International Benchmark Framework for Pediatric Liver Transplantation

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Bridge-to-Life-ILTS

More Like This

PR Newswire associated0

Bridge to Life Announces Abstract Presentations at The 2025 International Congress of the International Liver Transplantation Society (ILTS) in Singapore, May 28-31, 2025

PR Newswire associated0

Bridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May 6-9, 2026

PR Newswire associated0

Bridge to Life™ Unveils Groundbreaking 12-Month Clinical Trial Data on HOPE at World Transplant Congress 2025

PR Newswire associated0

New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation

PR Newswire associated0

First-Ever Multicenter Study of Hypothermic Oxygenated Perfusion (HOPE) with VitaSmart™ in Pediatric Liver Transplants Confirms Safety and Favorable Outcomes

PR Newswire associated0

Bridge to Life Presents New ILTS 2026 Data Showing VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) Expands Use of Marginal Donor Livers and Preserves Mitochondrial Function for Real-Time Viability Assessment

PR Newswire associated0

Landmark Study Published in the Journal of the American Medical Association (JAMA) Surgery Validates Bridge to Life's VitaSmart™ HOPE Perfusion System as a Superior Organ Preservation Technology

PR Newswire associated0

Italian Studies Confirm Safety of HOPE (Hypothermic Oxygenated PErfusion) for Liver Transplantation and Value of HOPE in Identifying Biomarkers for Assessing Liver Viability